SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Panel Urges More Testing for Diabetes Drugs

July 28, 2008 | 
1 min read
NEW YORK (Associated Press) - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.
FDA Approvals Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
FDA
FDA’s Prasad Weathers Personal Controversy, Internal Strife Amid Moderna Imbroglio
February 12, 2026
 · 
2 min read
 · 
Dan Samorodnitsky
Contemporary artwork. Businessman jumping over bear trap with briefcase and documents. Concept of business risk, hidden financial dangers, legal pitfalls, investment fraud and consumer protection.
Vaccines
Flu Vaccine Rejection Imperils Moderna’s Breakeven Plans
February 12, 2026
 · 
4 min read
 · 
Dan Samorodnitsky
Pictured: A syringe broken in half with long hallway in background/Nicole Bean for BioSpace
Regulatory
HHS Backs Prasad Amid Moderna Flu Shot Blowback
February 12, 2026
 · 
2 min read
 · 
Tristan Manalac
Syringe and a vial above the map of the USA. Illustration of the concept of the vaccination and immunization in the United States
Vaccines
FDA Refuses To Review Moderna’s mRNA Flu Vaccine, Claims Trial Inadequacies
February 11, 2026
 · 
4 min read
 · 
Tristan Manalac